Rep. Brian K. Fitzpatrick

Maddy summaryThis bill mandates an interagency review by the Department of Health and Human Services (with Defense and Veterans Affairs) to address lung cancer disparities affecting women. It requires a report evaluating research gaps, improving access to lung cancer screening (especially for underserved groups), and developing public awareness campaigns about early detection. The review will focus on factors like environmental exposures, genomic differences, and treatment responses specific to women, particularly those who never smoked. The report must be submitted to Congress within one year of enactment. This directly affects women at risk of lung cancer, including those with non-smoking-related cases.

Maddy summaryThis bill expands Medicare coverage to include home infusion treatment for people with Alpha-1 Antitrypsin Deficiency Disorder, a genetic condition causing lung and liver damage. It specifically covers "augmentation therapy" (a standard treatment using Alpha-1 Proteinase Inhibitor) when administered in a patient's home by qualified providers. Medicare will pay 80% of the cost for intravenous kits and up to 2 hours of nursing care during these home infusions, starting January 1, 2025. The change directly affects Medicare beneficiaries with this condition who require home-based treatment and their qualified home infusion providers.

Maddy summaryThis bill prohibits Medicare from paying for certain custom-fitted or custom-fabricated orthotic and prosthetic devices delivered via "drop shipment" (direct shipping without in-person training from a qualified provider). It directly affects Medicare beneficiaries who need these devices, ensuring they receive necessary in-person fitting and training. The bill also expands which healthcare professionals (including physical therapists, occupational therapists, orthotists, and prosthetists) can prescribe these devices and updates definitions to clarify terms like "orthoses" and "prostheses." Final regulations implementing these changes must be issued within one year of the bill's enactment.

Maddy summaryThe Comprehensive Cancer Survivorship Act (HR 4363) establishes new Medicare and Medicaid coverage for cancer care planning and coordination services, requiring personalized survivorship care plans for cancer survivors from diagnosis through the end of life. The bill creates a demonstration program to test different models of survivorship care, including navigation services to help survivors transition from cancer treatment to ongoing care, and mandates Medicaid coverage for cancer fertility services. It also establishes a comprehensive cancer survivorship program with resource centers for survivors and health care providers, and includes provisions to help cancer survivors overcome employment barriers and improve their quality of life through physical activity and mental health support. The legislation specifically addresses disparities in care for racial/ethnic minorities, lower socioeconomic groups, and rural populations who face unique challenges as cancer survivors.

Maddy summaryThis bill expands access to lung cancer screening by requiring Medicaid, Medicare, and private insurance plans to cover annual screenings without cost-sharing or prior authorization for individuals meeting U.S. Preventive Services Task Force guidelines. It also removes pregnancy-based restrictions on tobacco cessation services, extending coverage for counseling and medications to all Medicaid enrollees. The law applies to all Medicaid beneficiaries, Medicare participants, and private insurance plans starting January 2024, eliminating barriers like co-pays or pre-approval for recommended screenings. Additional provisions include $10 million annually for public education campaigns and a federal study on under-screened lung cancer demographics.

Maddy summaryThe ARC Act of 2023 establishes a national program to address peripheral artery disease (PAD), which disproportionately affects minority populations and leads to avoidable amputations. The bill requires Medicare and Medicaid to cover PAD screening tests (such as ankle-brachial index testing) for at-risk beneficiaries without cost-sharing, including people 65+ or those with diabetes, smoking history, or other risk factors. It authorizes $6 million annually for a CDC-led education program to inform healthcare providers and the public about PAD prevention and treatment. The bill also creates quality measures to encourage alternative treatments to amputation and establishes a pilot program to test amputation prevention services at healthcare facilities. These provisions aim to reduce amputation rates and improve outcomes for millions of Americans with PAD.

Maddy summaryHR 4034 would add cranial prostheses (such as medical wigs) to Medicare's list of covered durable medical equipment. It requires a dermatologist, oncologist, or attending physician to certify in writing that the prosthesis is medically necessary as part of rehabilitative treatment. This change directly affects Medicare beneficiaries experiencing hair loss due to medical conditions like cancer treatment who need these prostheses for health reasons. The bill does not cover cosmetic wigs but specifically targets medically necessary cranial prostheses under existing Medicare coverage rules.

Maddy summaryHR 3875, the Expanded Telehealth Access Act, expands Medicare coverage for telehealth services by adding new healthcare professionals to the list of providers eligible for payment. It specifically includes licensed audiologists, occupational therapists (and their assistants under supervision), physical therapists (and their assistants under supervision), and speech-language pathologists. The bill ensures these providers are paid the same rate for telehealth services as they would be for in-person care under Medicare. This change directly affects Medicare beneficiaries seeking remote therapy services and the new provider types who can now offer these services via telehealth.

Maddy summaryHR 3851, the Access to Breast Cancer Diagnosis Act of 2023, requires most health insurance plans (including group and individual coverage) to cover diagnostic and supplemental breast exams without any out-of-pocket costs like copays or deductibles. This applies to medically necessary exams used to evaluate abnormalities detected during screening (diagnostic) or to screen high-risk individuals without abnormalities (supplemental), following National Comprehensive Cancer Network guidelines. Plans may still require prior authorization for these exams, and state laws providing stronger protections remain in effect. The law takes effect for plan years beginning January 1, 2024.

Maddy summaryHR 3842, the Expanding Access to Diabetes Self-Management Training Act of 2023, would improve Medicare coverage for diabetes self-management training (DSMT) services for beneficiaries with diabetes. The bill expands provider eligibility to include nonphysician practitioners (like nurse practitioners), increases available training hours (initial 10 hours plus up to 2 hours annually), and requires 100% Medicare coverage with no out-of-pocket costs for beneficiaries. It also mandates a new demonstration project starting in 2025 to test virtual DSMT services, evaluating impacts on health outcomes (like A1c levels), hospitalizations, and program costs. This legislation directly affects Medicare beneficiaries with diabetes and healthcare providers offering DSMT services.